NGM Bio to Present at the Cowen 41st Annual Health Care Conference
February 25 2021 - 8:00AM
NGM Biopharmaceuticals, Inc. (NGM) (Nasdaq: NGM), a biotechnology
company focused on discovering and developing transformative
therapeutics for patients, today announced that David J. Woodhouse,
Ph.D., Chief Executive Officer, will present an overview of the
company and provide a business update at the Cowen 41st Annual
Health Care Conference on Thursday, March 4, at 11:10 am ET.
A live webcast of the presentation will be available under the
Investors and Media section of NGM’s website
at https://ir.ngmbio.com/events-presentations. A replay of the
presentation will be archived on NGM’s site for 30 days following
the event.
About NGM Biopharmaceuticals, Inc.
NGM is a biopharmaceutical company focused on discovering and
developing novel therapeutics based on scientific understanding of
key biological pathways underlying liver and metabolic diseases,
retinal diseases and cancer. We leverage our biology-centric drug
discovery approach to uncover novel mechanisms of action and
generate proprietary insights that enable us to move rapidly into
proof-of-concept studies and deliver potential first-in-class
medicines to patients. At NGM, we aspire to operate one of the most
productive research and development engines in the
biopharmaceutical industry, with multiple programs in clinical
development. Visit us at www.ngmbio.com for more information.
Investor
Contact:Alex Schwartzir@ngmbio.com |
Media
Contact:Liz Melonemedia@ngmbio.com |
NGM Biopharmaceuticals (NASDAQ:NGM)
Historical Stock Chart
From Sep 2024 to Oct 2024
NGM Biopharmaceuticals (NASDAQ:NGM)
Historical Stock Chart
From Oct 2023 to Oct 2024